TimesSquare Capital Management’s Xenon Pharmaceuticals XENE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$20.9M	Sell	359,293 -173,447	-33%	-$7.99M	0.35%	102
2025 Q4	$23.9M	Sell	532,740 -24,060	-4%	-$1.01M	0.36%	103
2025 Q3	$22.4M	Sell	556,800 -14,442	-3%	-$509K	0.32%	107
2025 Q2	$17.9M	Sell	571,242 -174,309	-23%	-$5.69M	0.26%	119
2025 Q1	$25M	Sell	745,551 -103,299	-12%	-$3.92M	0.4%	89
2024 Q4	$33.3M	Buy	848,850 +70,557	+9%	+$2.92M	0.48%	90
2024 Q3	$30.6M	Buy	778,293 +23,800	+3%	+$960K	0.46%	87
2024 Q2	$29.4M	Buy	754,493 +17,320	+2%	+$692K	0.46%	87
2024 Q1	$31.7M	Sell	737,173 -56,781	-7%	-$2.61M	0.46%	90
2023 Q4	$36.6M	Buy	793,954 +203,379	+34%	+$7.19M	0.54%	77
2023 Q3	$20.2M	Buy	590,575 +163,650	+38%	+$6.12M	0.31%	116
2023 Q2	$16.4M	Buy	426,925 +19,130	+5%	+$760K	0.24%	134
2023 Q1	$14.6M	Sell	407,795 -74,385	-15%	-$2.75M	0.21%	144
2022 Q4	$19M	Buy	+482,180	New	+$17.6M	0.27%	134